Canadian Cancer Trials Group Bulletins

General


Trial Activation

Canadian Cancer Trials Group IND.207 -- A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma -- was centrally activated on November 30, 2011.